Results 151 to 160 of about 23,382 (272)

Herpes Simplex Virus Hepatitis: An Overlooked Cause of Acute Liver Failure Across a Broad Spectrum of Immunocompromise

open access: yesLiver International, Volume 46, Issue 7, July 2026.
ABSTRACT Background and Aims Herpes simplex virus (HSV) infection is common worldwide, but hepatic involvement is rare. HSV hepatitis is an uncommon yet frequently catastrophic cause of acute hepatitis and acute liver failure (ALF), accounting for < 1% of ALF cases while carrying very high mortality when diagnosis and antiviral therapy are delayed ...
Mario U. Mondelli   +5 more
wiley   +1 more source

Dental Professionals' Attitudes Toward Treating Patients With Sensory Impairments: A Cross‐Sectional Survey

open access: yesSpecial Care in Dentistry, Volume 46, Issue 4, July/August 2026.
ABSTRACT Aims To analyze and compare the attitudes, perceived barriers, and professional confidence of dental students and practicing dentists toward treating patients with sensory impairments, and to examine associations with prior clinical experience and personal connection to disability.
Amir Laviv   +3 more
wiley   +1 more source

Harnessing Cellular Feeling: Epigenetic to Mechanical Memory as a Framework for Stem Cell Manufacturing

open access: yesBiotechnology and Bioengineering, Volume 123, Issue 6, Page 1481-1490, June 2026.
ABSTRACT Stem cell‐based therapies hold transformative potential for regenerative medicine, yet their progress is constrained by persistent variability in manufacturing and clinical performance. Conventional frameworks such as Quality by Design (QbD), though effective for drugs and biologics, struggle to accommodate the dynamic nature of living cell ...
Mee‐Hae Kim, Masahiro Kino‐oka
wiley   +1 more source

Efficacy of Disitamab Vedotin in Treating HER2 2+/FISH‐Bladder Cancer: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 6, June 2026.
Timeline of treatment and sustained partial response in a patient with HER2 2+/FISH‐ bladder cancer (October 2019 – June 2024). ABSTRACT Disitamab Vedotin achieved durable partial response (> 8 months PFS) in advanced HER2 2+/FISH‐ bladder cancer after first‐line chemo‐immunotherapy progression.
Zhi‐ruo Jin   +8 more
wiley   +1 more source

A Predicted FEV1/FVC Model Based on a Simple Respiratory Questionnaire for Early Diagnosis of COPD in Shimane Cohort, Japan. [PDF]

open access: yesInt J Chron Obstruct Pulmon Dis
Nakao M   +9 more
europepmc   +1 more source

What's Your Diagnosis? Large Mediastinal Mass in a Dog

open access: yes
Veterinary Clinical Pathology, EarlyView.
Rosane O. Cruz   +7 more
wiley   +1 more source

Cytogenetic and Molecular Analysis of a “Double‐Hit” RUNX1 Including a RUNX1 p.Trp279* and a Cryptic Novel t(6;21)(q25;q22)/RUNX1::ARID1B in Acute Myeloid Leukemia

open access: yesGenes, Chromosomes and Cancer, Volume 65, Issue 6, June 2026.
ABSTRACT Introduction Alterations involving RUNX1 are recurrent in hematologic malignancies and contribute to disease pathogenesis via dysregulation of transcriptional factors essential for hematopoiesis. Here, we report an acquired alteration in both alleles of RUNX1; one is a truncating mutation and the second is a novel RUNX1::ARID1B identified in ...
Rolando García   +8 more
wiley   +1 more source

Q12・Q13・Q14

open access: yesOkayama Igakkai Zasshi (Journal of Okayama Medical Association), 2016
openaire   +1 more source

Home - About - Disclaimer - Privacy